Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FHGLV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,777
Award facts
- Contract value 100% obligated
- $2,777.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,777.24 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Nexplanon 68 mg implants. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, with no set-aside designation applied. The order is being fulfilled from Park Ridge, Illinois, where the contractor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, has been registered in SAM.gov since 2001 and specializes in providing pharmaceutical products to federal agencies, particularly the Department of Defense healthcare system.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to deliver contraceptive devices, oncology treatments, vaccines, and other specialized pharmaceutical products to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FHGLV?
SPE2DB25FHGLV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FHGLV worth?
The government has obligated $2,777 on SPE2DB25FHGLV.
Is contract SPE2DB25FHGLV an order under another contract?
Yes. SPE2DB25FHGLV is a delivery order under SPE2DB24D9241, an indefinite delivery contract.
Was contract SPE2DB25FHGLV competed?
The extent of competition for SPE2DB25FHGLV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award